Company Filing History:
Years Active: 2005-2008
Title: The Innovative Contributions of Li Feng
Introduction
Li Feng is a prominent inventor based in Fremont, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of benzoquinone ansamycin analogs. With a total of 2 patents, her work is paving the way for new therapeutic options in combating diseases characterized by undesired cellular proliferation.
Latest Patents
Li Feng's latest patents focus on benzoquinone ansamycins. These inventions relate to benzoquinone ansamycin analogs that are useful for the treatment of cancer and other diseases or conditions characterized by undesired cellular proliferation or hyperproliferation. The therapies involving the administration of such benzoquinone ansamycin analogs, optionally in combination with an inhibitor of an HSP90 client protein, are particularly promising for treating both cancerous and non-cancerous disease conditions.
Career Highlights
Li Feng is currently associated with Kosan Biosciences Incorporated, where she continues to advance her research in the field of oncology. Her work has garnered attention for its potential impact on cancer therapies, showcasing her dedication to improving patient outcomes through innovative solutions.
Collaborations
Li Feng collaborates with notable colleagues, including Daniel V Santi and David C Myles. These partnerships enhance her research efforts and contribute to the development of effective treatments.
Conclusion
Li Feng's contributions to the field of cancer treatment through her innovative patents highlight her role as a leading inventor. Her work not only demonstrates her expertise but also reflects her commitment to advancing medical science for the benefit of patients.